GSK plc (GSK)
NYSE: GSK · Real-Time Price · USD
35.03
+0.72 (2.08%)
Dec 3, 2024, 1:14 PM EST - Market open
GSK Employees
GSK plc had 70,212 employees as of December 31, 2023. The number of employees increased by 812 or 1.17% compared to the previous year.
Employees
70,212
Change (1Y)
812
Growth (1Y)
1.17%
Revenue / Employee
$597,707
Profits / Employee
$47,933
Market Cap
69.22B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 70,212 | 812 | 1.17% |
Dec 31, 2022 | 69,400 | -20,696 | -22.97% |
Dec 31, 2021 | 90,096 | -3,970 | -4.22% |
Dec 31, 2020 | 94,066 | -5,371 | -5.40% |
Dec 31, 2019 | 99,437 | 3,947 | 4.13% |
Dec 31, 2018 | 95,490 | -2,972 | -3.02% |
Dec 31, 2017 | 98,462 | -838 | -0.84% |
Dec 31, 2016 | 99,300 | -1,955 | -1.93% |
Dec 31, 2015 | 101,255 | 3,334 | 3.40% |
Dec 31, 2014 | 97,921 | -1,530 | -1.54% |
Dec 31, 2013 | 99,451 | -37 | -0.04% |
Dec 31, 2012 | 99,488 | 2,099 | 2.16% |
Dec 31, 2011 | 97,389 | 928 | 0.96% |
Dec 31, 2010 | 96,461 | -3,452 | -3.46% |
Dec 31, 2009 | 99,913 | 910 | 0.92% |
Dec 31, 2008 | 99,003 | -4,480 | -4.33% |
Dec 31, 2007 | 103,483 | 788 | 0.77% |
Dec 31, 2006 | 102,695 | 1,967 | 1.95% |
Dec 31, 2005 | 100,728 | 709 | 0.71% |
Dec 31, 2004 | 100,019 | -900 | -0.89% |
Dec 31, 2003 | 100,919 | -3,580 | -3.43% |
Dec 31, 2002 | 104,499 | -2,971 | -2.76% |
Dec 31, 2001 | 107,470 | -47 | -0.04% |
Dec 31, 2000 | 107,517 | -1,524 | -1.40% |
Dec 31, 1999 | 109,041 | -7,780 | -6.66% |
Dec 31, 1998 | 116,821 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
HCA Healthcare | 310,000 |
CVS Health | 300,000 |
Becton, Dickinson and Company | 73,000 |
McKesson | 51,000 |
Takeda Pharmaceutical | 49,281 |
Cencora | 46,000 |
Haleon | 25,408 |
Alcon | 25,315 |
GSK News
- 11 days ago - GSK's RSV vaccine gets Japan approval for adults aged 50 to 59 - Reuters
- 14 days ago - GSK share price is imploding: is it safe to buy the dip? - Invezz
- 14 days ago - GSK drug meets main goal in late-stage study to treat relentless itch - Reuters
- 17 days ago - As Drug Maker Stocks Fall, Pressure Builds On PhRMA To Derail RFK, Jr. - Forbes
- 18 days ago - GSK plc (GSK) Guggenheim's Inaugural Healthcare Innovation Conference (Transcript) - Seeking Alpha
- 18 days ago - European And US Vaccine Stocks Are Under Pressure - Here's WHy - Benzinga
- 18 days ago - Pharma shares hit as Trump picks RFK Jr to lead health department - The Guardian
- 18 days ago - Vaccine maker stocks fall on reports Trump plans to tap RFK Jr. to lead HHS - CNBC